Trials / Withdrawn
WithdrawnNCT01190722
A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain
A Randomized Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Karolinska Institutet · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that cyclooxygenas-II-selective inhibitors (Coxibs) provide a better patients assessed overall satisfaction when used for pain management after elective hallux valgus surgery as compared to traditional Non-steroidal anti-inflammatory drugs (NSAIDs).
Detailed description
The aim of the present study is to compare patients' satisfaction with pain medication during the first 7 first postoperative days following elective hallux valgus surgery in general anaesthesia between etoricoxib and diclofenac in a prospective randomised double-blind study design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | etoricoxib | 120 mg once daily for the 1st 6 postoperative days |
| DRUG | Diclofenac | 50 mg oral 3 times daily the 1st 6 postoperative days |
Timeline
- Start date
- 2010-11-10
- Primary completion
- 2010-12-11
- Completion
- 2010-12-12
- First posted
- 2010-08-30
- Last updated
- 2017-12-02
Source: ClinicalTrials.gov record NCT01190722. Inclusion in this directory is not an endorsement.